Robert Lorne Hopfner, Director at Vaxcyte, Inc. (PCVX), sold 175,222 shares at $25.74 ($4.5M) on 2021-01-15, disclosed to the SEC on 2021-01-19.
Open-market sale of $4.5M PCVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.88 | 14,918 | $386K | 8.6% |
| 2 | $25.88 | 14,918 | $386K | 8.6% |
| 3 | $25.74 | 22,869 | $589K | 13.1% |
| 4 | $25.74 | 22,869 | $589K | 13.1% |
| 5 | $26.05 | 3,808 | $99K | 2.2% |
| 6 | $26.05 | 3,808 |
| $99K |
| 2.2% |
| 7 | $25.55 | 42,516 | $1.1M | 24.1% |
| 8 | $25.55 | 42,516 | $1.1M | 24.1% |
| 9 | $26.05 | 7,000 | $182K | 4.0% |
| Total | $25.70 avg | 175,222 | $4.5M | 100% |
| Filing → |
| INZY | BUY | 2023-05-15 | $5.7M | — | Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |